Agrochemical giant Bayer has agreed to a nationwide settlement that could cost the company up to $7.25 billion. The deal, approved by a Missouri judge, compensates thousands of people diagnosed with non-Hodgkin lymphoma, a blood cancer they claim is linked to glyphosate, the main ingredient in Roundup. Bayer's CEO, Bill Anderson, called the settlement a "decisive milestone" that mitigates pending and future litigation risks.
The settlement, one of the largest mass tort personal-injury class action settlements, provides $10,000 to $165,000 in compensation to affected individuals. Payouts depend on factors such as occupation, exposure levels, and age at diagnosis. Plaintiffs' attorney Christopher Seeger stated that the approval order delivers guaranteed compensation to Roundup cancer victims who have waited over a decade for justice.
This settlement is in addition to a previous $10 billion to $11 billion deal to settle over 100,000 Roundup-related claims. The World Health Organization's cancer agency concluded over a decade ago that glyphosate is probably carcinogenic to humans. Despite this, Bayer has denied that its product causes cancer. The Environmental Protection Agency has also found no risks of concern from glyphosate uses, including for cancer.
The US Supreme Court recently ruled in favor of Bayer, shielding the company from state court lawsuits over alleged failure to warn consumers about glyphosate's cancer-causing effects. The Trump administration has supported the herbicide-maker, siding with Bayer in the Supreme Court case and issuing an executive order to promote domestic glyphosate production.
Concerns about glyphosate safety have been a key issue for Health Secretary Robert F. Kennedy Jr and his Make America Healthy Again agenda. However, Bayer has maintained that Roundup is safe. The company removed glyphosate from its US residential products but continues to use it in the agricultural industry.
The settlement's approval comes after years of litigation and negotiations. According to Judge Timothy Boyer, it is among the largest in mass tort personal-injury class action settlements history. Bayer's Roundup is the most widely used weed-killer globally.
The deal provides closure for thousands of affected individuals and their families. As part of the settlement, Bayer will pay out significant sums over the coming years. The company's statement emphasized that the settlement allows it to focus on its future.
Key points
- Bayer agrees to pay up to $7.25 billion to settle US lawsuits alleging Roundup causes cancer.
- The settlement provides $10,000 to $165,000 in compensation to affected individuals.
- This is one of the largest mass tort personal-injury class action settlements in history.